type 2 diabetes is a surgical disease

Similar documents
Management of Type 2 Diabetes

Other Ways to Achieve Metabolic Control

New insights in metabolic surgery

Bariatric surgery as a model for obesity research. Nick Finer BSc, FRCP, FAfN University College London UK

Roux-and-Y Gastric Bypass and its Metabolic Effects

Current Status of Bariatric Surgery in Asia

What is Metabolic About Metabolic Surgery? The New ADA Recommendations

Appetite, Glycemia and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant and Duodenal Administration of a Mixed Meal Test After

A Bariatric Patient in my Waiting Room: Choosing the Right Patient for the Right Operation: Bariatric Surgery Indications

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Technique. Matthew Bettendorf, MD Essentia Health Duluth Clinic. Laparoscopic approach One 12mm port, Four 5mm ports

Diabetes: What is the scope of the problem?

la prise en charge du diabète de

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes

CME Post Test. D. Treatment with insulin E. Age older than 55 years

Current Trends in Bariatric Surgery

MULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES IN OBESE PATIENTS

Achttiende diabetessymposium Bariatrische heelkunde pros en cons. B.J. Van der Schueren

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS

Role of Malabsorptive Endoscopic Procedures in Obesity Treatment

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

New Insights into Mechanism of Action

Choice Critria in Bariatric Surgery. Giovanni Camerini

Disclosure Medtronic - Speaker/ Research Grant/ Robotics Advisory Board Gore - Education Grant/ Speaker Teleflex - Consultant Da Vinci - Proctor

Bariatric surgery. KHALAJ A.R. M.D Obesity Clinic Mostafa Khomini Hospital Shahed University Tehran

Sleeve Gastrectomy Debate: Everyone Needs a Sleeve!!! Dana Portenier, MD Assistant Professor of Surgery Duke University Medical Center

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric

Obesity Management Workshop for Health Professionals

Obesity and Bariatric Surgery Michel M. Murr, MD, FACS

Metabolic Interventions and the GI Tract: Issues

Chief of Endocrinology East Orange General Hospital

6/10/2016. Bariatric Surgery: Impact on Diabetes and CVD Risk. Disclosures BARIATRIC PROCEDURES

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Dianne Kristine Joy Closa*, Armin Masbang, Dianne Shari Cabrera, Allan Dampil and Robert Mirasol

Metabolic Surgery for Type 2 Diabetes - Window into Pathophysiology-

Bariatric surgery: has anything changed in the last few years?

Understanding the Effects of Roux-en-Y Gastric Bypass (RYGB) Surgery on Type 2 Diabetes Mellitus

* Assit. prof., *** Prof. & Head of deptt., Deptt. of Surgery, MGIMS ** Asstt prof Deptt. of Medicine. REVIEW ARTICLE

Bariatric Surgery: The Primary Care Approach

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None

Index. Note: Page numbers of article titles are in boldface type.

SURGICAL TREATMENT FOR OBESITY: WHATS THE BEST OPTION? Natan Zundel, MD, FACS

Laparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type II Diabetes Mellitus in Chinese Patients with Body Mass Index of 25 35

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

4. Mechanisms Mediating Weight Loss and Diabetes Remission After Bariatric/ Metabolic Surgery

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST Integration 04/28/2017 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Bariatric Surgery: A Cost-effective Treatment of Obesity?

Bariatric Procedures and Mechanisms of Weight Loss. September 22 nd, 2018 Aryan Modasi MD MSc FRCSC

Chairman s Rounds, 02/15/2011

Policy Specific Section: April 14, 1970 June 28, 2013

Surgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008

Obesity Who is suitable for surgery? Professor Rob Andrews University of Exeter / Taunton NHS trust

Gastric Emptying Time after Laparoscopic Sleeve Gastrectomy

Key points Obesity is an increasing problem with rates continuing to rise Treatment for OSAHS is poorly tolerated but surgical weight loss has good

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

Megan Lawless. Journal Club. January 20 th, 2011

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018

Abstract. Effect of sitagliptin on glycemic control in patients with type 2 diabetes. Introduction. Abbas Mahdi Rahmah

The Obesity Epidemic: Is There A Surgical Solution? Mr Roger Ackroyd Consultant Surgeon Northern General Hospital Sheffield UK

What s New About Metabolic Surgery?

Update on Bariatric Surgery. Learning Objectives: At the end of this lecture you should be able to: Currently Available Options

Obesity & Metabolic (Diabetes) Surgery

SURGICAL CURES FOR DIABETES

Gastric By-Pass and Remission of Type II Diabetes in Obese Adults

Comparison Between Laparoscopic Sleeve Gastrectomy and Laparoscopic Adjustable Gastric Banding for Morbid Obesity: a Meta-analysis

Endorsed by Executive Council June 17, American Society for Metabolic and Bariatric Surgery

ORIGINAL ARTICLE. A Prospective Cohort Study of Laparoscopic Sleeve Gastrectomy vs Medical Treatment

Laparoscopic Adjustable Gastric Band The Safest, Effective Procedure for Treating Obesity and Obesity Related Disease

What s New in Bariatric Surgery?

The Changing Shape of Bariatric Surgery

Medicare Part C Medical Coverage Policy

THE ROLE OF THE PROXIMAL SMALL INTESTINE IN IMPROVEMENTS IN DIABETES RESOLUTION AND INSULIN SENSITIVITY FOLLOWING BARIATRIC

Type 2 diabetes and metabolic surgery:

OBESITY MANAGEMENT: DIET/EXERCISE, NEW DRUGS AND/OR SURGERY?

3. Metabolic Surgery and Control of Type 2 Diabetes

Medical Policy Bariatric Surgery. Document Number: 042 Commercial and Qualified Health Plans MassHealth Authorization required X X

Associate. Professor of. Minimally. Invasive Surgery

Chapter 4 Section 13.2

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

The Surgical Management of Obesity

Management of diabetes with Bariatric surgery. Muhammad Jawad MD FACS FASMBS

Overview. Stanley J. Rogers, MD, FACS Associate Clinical Professor of Surgery University of California San Francisco

10/28/11. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

Not over when the surgery is done: surgical complications of obesity

Bariatric Care Center Outcomes Report

Chapter 4 Section 13.2

Impact of bariatric surgeries on diabetes outcomes

Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore

Obesity and Sleep Apnea: Evaluating the Bariatric Surgery Option

Therapeutic strategy to reduce Glucagon secretion

Benefits of Bariatric Surgery

Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus

Bariatric Surgery. Overview of Procedural Options

Morbid Obesity A Curable Disease?

Corporate Medical Policy. Bariatric (Surgery for Morbid Obesity)

Viriato Fiallo, MD Ursula McMillian, MD

Protocol. Bariatric Surgery

Diabesita : integrazione tra terapia medica e terapia chirurgica Prof. Monica Nannipieri Dip. Medicina Clinica e Sperimentale Università di Pisa

Disclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery

Transcription:

M. Lannoo, MD, University Hospitals Leuven Walter Pories claimed in 1992 type 2 diabetes is a surgical disease Buchwald et al. conducted a large meta-analysis THE FIRST OBSERVATIONS W. Pories 500 patients Long term sufficient weight loss Adequate follow up 163 studies 22,094 patients Surgical procedures Gastric Banding Gastric Bypass (Roux en Y) Gastroplasty Bilio-pancreatic Diversion Assesment of comorbities Diabetes Hypertension Hypercholesterolemia Obstructive Sleep Apnea N Engl J Med. 2007 Aug 23;357(8):741-52.) 1

100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Resolution or improvement (% of patients) Diabetes AHT Hyperchol OSAS Buchwald et al. conducted a large meta-analysis (Buchwald H, Avidor Y,Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta analysis. Jama. 2004 Oct 13;292(14):1724-37) For all surgical procedures combined type 2 diabetes Resolved in 76.8% Resolved or improved in 86% of patients Complete remission by type of surgery 48% after gastric banding (operative mortality 0.1%) 84% after Roux en Y (operative mortality 0.5%) >95% after bilio-pancreatic diversion (operative mortality 1.1%) Remission of diabetes after gastric banding occurs over several weeks or month, whereas after gastric bypass it can occur within days OBSERVATIONS: mortality Sjöström et al. The Swedisch Obesity Study (SOS trial) Prospective, controlled Swedish Obese Subjects study. Effect= mainly 2010 underwent bariatric CVD surgery of DM pat (surgery group) 2037 received conventional treatment (matched control group). But not randomized, treatment of the control group not well defined, more pre-baseline cardiovascular events in controls The Swedisch Obesity Study (SOS trial) N Engl J Med. 2007 Aug 23;357(8):741-52.) Sjostrom L et al. n engl j med; 351;26, 2004 OBSERVATIONS: mortality OBSERVATIONS:sleeve gastrectomy Adams et al. N Engl J Med 357;8 august 2007 2

OBSERVATIONS:sleeve gastrectomy author N %EWL 1y IDDM 2 AHT Sleep apnoea OBSERVATIONS:sleeve gastrectomy R DURATION OF DIABETES IS IMPORTANT Moon Han 130 83 100% 93% 100% Cottam 126 45 75% 75% 80% Sillechia 41 77% 63% 56,2% Vidal 39 63 85% Kasalicky 61 72 71% 65% Rosenthal et al Surg Obes Relat Dis 2009 Epub corrected proof REMARKABLE ANALOGY WITH RYGBP Tagaya 30 67% 56% Akkary Obes Surg 2008 18:1323-1329 13 Ingestion of food GI tract Adapted from Brubaker PL, Drucker DJ Endocrinology 2004;145:2653 2659; Zander M et al Lancet 2002;359:824 830; Ahrén B Curr Diab Rep 2003;3:365 372; Buse JB et al. In Williams Textbook of Endocrinology. 10th ed. Philadelphia, Saunders, 2003:1427 1483. MECHANISMS: entero-insular axis Release of incretin gut hormones Active GLP-1 and GIP Pancreas Beta cells Alpha cells Glucose dependent Insulin from beta cells (GLP-1 and GIP) Glucagon from alpha cells (GLP-1) Glucose dependent Insulin increases peripheral glucose uptake Increased insulin and decreased glucagon reduce hepatic glucose output Blood glucose control MECHANISMS: entero-insulinar axis and type 2 DM? Insulin deficiency Islet MECHANISMS: entero-insulinar axis and surgery Excess glucagon Pancreas Alpha cell produces excess glucagon Diminished insulin Beta cell produces less insulin Hypothesis of the proximal bowel Diminished insulin Hyperglycemia Muscle and fat Liver Excess glucose output Insulin resistance (decreased glucose uptake) Adapted from Buse JB et al. In Williams Textbook of Endocrinology. 10th ed. Philadelphia, Saunders, 2003:1427 1483; Hypothesis of the distal bowel Buchanan TA Clin Ther 2003;25(suppl B):B32 B46; Powers AC. In: Harrison s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill, 2005:2152 2180; Rhodes CJ Science 2005;307:380 384. 3

MECHANISMS: entero-insulinar axis and surgery Surgical procedures Physiology: entero-insular axis Hypothesis of the distal bowel: Expedited of nutrients to the distal bowel enhances a physiologic signal that improves glucose metabolism (GLP- 1) Hypothesis of the proximal bowel: Exclusion of duodenum and proximal jejunum may prevent secretion of a putative signal that promotes insuline resistance (involvement of the proximal small intestine in the physiology of IR. Hypoglycemia Insulin resistance Nesidioblastosis MECHANISM: sleeve gastrectomy Mechanisms of DM resolution after Sleeve gastrectomy RYGBP SLEEVE Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy Nicola Basso OBES SURG (2010) 20:50 55 Karamanakos et al Ann of Surg 2008;247(3):401-7 22 INDICATIONS : Lower BMI in type 2 DM Rubino et al.: Effect of Duodenal Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes LEAN TYPE 2 DIABETEIC RATS Rubino F. Ann Surg. 2004 Jan;239(1):1-11. 4

INDICATIONS : Lower BMI in type 2 DM Quote of Professor Scopinaro Why should you treat a disease September 15-16th 2008 When you can cure it!!!! 1 ste World Congress on Interventional therapies for type INDICATIONS : Lower BMI in type 2 DM Early Postoperative Outcomes of Metabolic Surgery to Treat Diabetes LAGB vs RYGBP BMI 30<>35 DM TYPE 2 % resolution 3-6 months 6-12 months BMI 3-6 months 6-12 months RYGBP 50 55,2 27,2 27,1 Lap Banding 31,8 27,5 31 30,9 P 0,0579 0,0199 <0,0001 0,0002 2 Diabetes; September 15-16th 2008 From Sites Participating in the ASMBS BSCOE Program as Reported in the BOLD Eric J. DeMaria, MD, Walter J. Pories, MD Annals of Surgery Volume 252, Number 3, Sept. 2010 Issues on diabetes Insulin resistance Issues on diabetes Unhealthy lifestyle and environmental factors + Metabolic syndrome Increased risk of cardiovascular disease Unhealthy lifestyle and environmental factors + Genes Environment Inflammation Free fatty acid Glucose Hyperglycaemia Healthy beta-cells Failing beta-cells Type 2 diabetes Rubino 5

COULD NOT REPRODUCE THE RESULT ON DM W. PORIES Insulin resistance did not change either Walter J. Pories, G. Lynis Dohm, Obes Surg. 2010 Nov 18. Epub ahead of print Walter J. Pories, G. Lynis Dohm, Obes Surg. 2010 Nov 18. Epub ahead of print WEIGHT REGAIN IS STRONGLY ASSOCIATED WITH RELAPSE OF DM Lower preoperative BMI is also contributing factor WEIGHT LOSS IS IMPORTANT! Possible mechanisms: -Increased calory intake -Increased fat mass -Adaptation of the gut Further research is needed Surg Obes Relat Dis. 2010 DiGiorgi M, Bessler M. CALORIC RESCTRICTION is IMPORTANT BYPASS VERSUS NO OPERATION DIET ONE WEEK IDENTICAL FOR BOTH RYGBP CHANGES HORMONES INSULINE RESISTANCE IS CHANGED BY CALORY RESTRICTION CONCLUSIONS It is an absolute indication to operate on type 2 diabetes patients with a BMI > 35 We have to do it as soon as possible: beta cell function metabolic memory More knowledge about DM 2 and mechanisms of surgery will lead to Patient tailored approaches with different kind of operations Better predictive tools than BMI Untill then new indications or operation have to be conducted in trials with adequate outcome parameters JAMES M. ISBELL, NAJI N. ABUMRAD,DIABETES CARE, VOLUME 33, NUMBER 7, JULY 2010 6

NEW DEVICES NEW DEVICES NEW OPERATIONS NEW OPERATIONS An ileal interposition with a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. DepaulaAL, Surg Endosc 2008 Oct 2. 7